RxDoctor Payments Data

Allison Stewart, PA

Physician Assistant · St George, UTNPI 1578058475

Payments from drug & device makers

$1,490in general payments, 2019–2025

Across 98 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$671
  • AstraZeneca$198
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$93
  • Alkermes, Inc.$72
  • Indivior Inc.$65
  • Biohaven Pharmaceuticals, Inc.$59
  • plus $332 from 14 others

What the payments were for

  • Food & beverage$1,490100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,490 in reported general payments places this provider in the 75th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$3,743
Medicare patients
44
Services billed
249

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol34$52,040
Xigduo XrDapaglifloz Propaned/Metformin36$49,140
XareltoRivaroxaban27$43,229
EliquisApixaban39$41,369
TrulicityDulaglutide29$32,934
VraylarCariprazine Hcl21$29,563
OzempicSemaglutide26$24,870
LinzessLinaclotide17$21,219
Tresiba Flextouch U-100Insulin Degludec15$16,320
TradjentaLinagliptin18$14,554
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$3,123
Gabapentin81$1,645
Atorvastatin Calcium178$1,528
Omeprazole78$1,169
Levothyroxine Sodium85$1,059

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$198$52,04034 claims
AbbVieVraylar, Linzess$671$50,78238 claims
Johnson & JohnsonXarelto$36$43,22927 claims
Lilly USA, LLCTrulicity$14$32,93429 claims
Novo NordiskOzempic$20$24,87026 claims
Boehringer IngelheimTradjenta$41$14,55418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in St George

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →